| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 56.51▼ | 56.80▼ |
| MA10 | N/A | N/A | N/A | 56.67▼ | 56.75▼ |
| MA20 | N/A | N/A | N/A | 56.68▼ | 55.30▲ |
| MA50 | N/A | N/A | N/A | 56.68▼ | 50.02▲ |
| MA100 | N/A | N/A | N/A | 55.00▲ | 44.88▲ |
| MA200 | N/A | N/A | N/A | 50.47▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | -0.084▼ | -0.169▼ |
| RSI | N/A | N/A | N/A | 48.205▼ | 64.121▲ |
| STOCH | N/A | N/A | N/A | 33.556 | 64.451 |
| WILL %R | N/A | N/A | N/A | -72.000 | -24.038▲ |
| CCI | N/A | N/A | N/A | -36.937 | 42.277 |
|
Wednesday, April 30, 2025 06:36 AM
GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14 ...
|
|
Tuesday, April 15, 2025 05:00 PM
In a report released yesterday, Michael Huttner from Berenberg Bank maintained a Buy rating on ageas NV (0Q99 – Research Report), with a price target of €60.00.
|
|
Tuesday, January 28, 2025 04:26 PM
Berenberg Bank analyst Michael Huttner maintained a Buy rating on ageas NV (0Q99 – Research Report) yesterday and set a price target of €58.00. The company’s shares closed yesterday at €48 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 56.45 | 57.35 | 56.45 | 56.45 | 2 |
| 10/07/25 | 56.85 | 57.35 | 56.25 | 56.25 | 4 |
| 09/07/25 | 56.80 | 57.35 | 56.80 | 56.80 | 22 |
| 08/07/25 | 57.10 | 57.35 | 56.15 | 56.15 | 123 |
| 07/07/25 | 56.90 | 57.35 | 56.90 | 56.90 | 176 |
| 04/07/25 | 56.70 | 57.35 | 56.65 | 56.65 | 2 |
| 03/07/25 | 56.75 | 57.35 | 56.75 | 56.75 | 4 |
| 02/07/25 | 57.30 | 57.35 | 56.55 | 56.55 | 2 |
| 01/07/25 | 57.35 | 57.35 | 56.90 | 56.90 | 4 |
| 30/06/25 | 57.35 | 57.35 | 57.35 | 57.35 | 2,007 |
|
|
||||
|
|
||||
|
|